Jane Lowe Meisel (Jane L Meisel)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Sentinel Lymph Node

Peripheral Blood

Squamous Cell Carcinoma

Top Venues

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah J Wood, Yuan Gao, Ji-Hoon Lee, Jessica Chen, Qun Wang, Jane Lowe Meisel, Xiaoxian Li
High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy. Breast cancer research and treatment (2024)
Sarah J Wood, Yuan Gao, Ji-Hoon Lee, Jessica Chen, Qun Wang, Jane Lowe Meisel, Xiaoxian Li
High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy. Breast cancer research and treatment 205 (1) (2024)
Sarah J Wood, Yuan Gao, Ji-Hoon Lee, Jessica Chen, Qun Wang, Jane Lowe Meisel, Xiaoxian Li
High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy. Breast cancer research and treatment 205 (1) (2024)
Jane Lowe Meisel, Amy Harrington, Natalie Whaley, Wendy Vitek, Ruth M O'Regan
When the personal becomes political: The impact of the Dobbs decision on women with cancer. Cancer (2022)
Caitlin E Taylor, Jane Lowe Meisel
We have to talk about it: Bringing fertility into the conversation for young women with breast cancer. Cancer 127 (16) (2021)
Caitlin E Taylor, Jane Lowe Meisel
Weighing the influence of race and obesity on outcomes in patients with early-stage breast cancer. Cancer 127 (6) (2020)
Jane Lowe Meisel, Ruth M O'Regan
Race, breast cancer, and prognosis: Where biology is queen? Cancer 125 (18) (2019)